14-35091096-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The ENST00000261475.10(PPP2R3C):c.1087G>A(p.Val363Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000492 in 1,605,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000261475.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP2R3C | NM_017917.4 | c.1087G>A | p.Val363Ile | missense_variant | 11/13 | ENST00000261475.10 | NP_060387.2 | |
LOC101927178 | NR_110415.1 | n.480-8556C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP2R3C | ENST00000261475.10 | c.1087G>A | p.Val363Ile | missense_variant | 11/13 | 1 | NM_017917.4 | ENSP00000261475 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152158Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000843 AC: 21AN: 249248Hom.: 0 AF XY: 0.0000891 AC XY: 12AN XY: 134688
GnomAD4 exome AF: 0.0000275 AC: 40AN: 1453164Hom.: 0 Cov.: 30 AF XY: 0.0000346 AC XY: 25AN XY: 723180
GnomAD4 genome AF: 0.000256 AC: 39AN: 152276Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2023 | The c.1087G>A (p.V363I) alteration is located in exon 11 (coding exon 11) of the PPP2R3C gene. This alteration results from a G to A substitution at nucleotide position 1087, causing the valine (V) at amino acid position 363 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at